Bancel Stephane's Form 4 filing
Moderna, Inc. (MRNA) · filed Oct 28, 2022
- Accession no.
- 0001127602-22-024460
- Filed
- Oct 28, 2022
- Trade date
- Oct 26-27, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 2 derivative transactions. Open-market sales total $12.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bancel StephaneCIK 0001443340 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | Common Stock | MOption exerciseAcquired | +40,000 | $0.99 | +$39,600 | 5,451,946 | Direct | |
| Oct 26, 2022 | Common Stock | SSaleDisposed | −15,683 | $141.34F2 | −$2,216,635.22 | 5,436,263 | Direct | |
| Oct 26, 2022 | Common Stock | SSaleDisposed | −10,121 | $142.21F3 | −$1,439,307.41 | 5,426,142 | Direct | |
| Oct 26, 2022 | Common Stock | SSaleDisposed | −2,978 | $143.23F4 | −$426,538.94 | 5,423,164 | Direct | |
| Oct 26, 2022 | Common Stock | SSaleDisposed | −9,815 | $144.13F5 | −$1,414,635.95 | 5,413,349 | Direct | |
| Oct 26, 2022 | Common Stock | SSaleDisposed | −1,403 | $145.01F6 | −$203,449.03 | 5,411,946 | Direct | |
| Oct 27, 2022 | Common Stock | MOption exerciseAcquired | +40,000 | $0.99 | +$39,600 | 5,451,946 | Direct | |
| Oct 27, 2022 | Common Stock | SSaleDisposed | −14,748 | $143.05F7 | −$2,109,701.4 | 5,437,198 | Direct | |
| Oct 27, 2022 | Common Stock | SSaleDisposed | −24,252 | $143.90F8 | −$3,489,862.8 | 5,412,946 | Direct | |
| Oct 27, 2022 | Common Stock | SSaleDisposed | −1,000 | $144.96F9 | −$144,960 | 5,411,946 | Direct | |
| Oct 27, 2022 | Common Stock | SSaleDisposed | −10,000 | $143.38 | −$1,433,800 | 6,654,880 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 2,787,155 | Direct | |
| Oct 27, 2022 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 2,747,155 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.72 to $141.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.73 to $142.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.74 to $143.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.77 to $144.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.81 to $145.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.54 to $143.51. Full information regarding the number of shares sold at each separate price can befurnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.55 to $144.53. Full information regarding the number of shares sold at each separate price can befurnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.78 to $145.16. Full information regarding the number of shares sold at each separate price can befurnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.